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SUMMARY 
The biogenesis and function of the mitochondrial respiratory chain (RC) involve the 
organization of RC enzyme complexes in supercomplexes or respirasomes through an 
unknown biosynthetic process. This leads to structural interdependences between RC 
complexes, which are highly relevant from biological and biomedical perspectives, 
because RC defects often lead to severe neuromuscular disorders. We show that in 
human cells, respirasome biogenesis involves a complex I assembly intermediate acting 
as a scaffold for the combined incorporation of complexes III and IV subunits, rather 
than originating from the association of preassembled individual holoenzymes. The 
process ends with the incorporation of complex I NADH dehydrogenase catalytic 
module, which leads to the respirasome activation. While complexes III and IV 
assemble either as free holoenzymes or by incorporation of free subunits into 
supercomplexes, the respirasomes constitute the structural units where complex I is 
assembled and activated, thus explaining the significance of the respirasomes for RC 
function. 
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HIGHLIGHTS 
1) Mitochondrial respirasome biogenesis is a multistep biosynthetic process 
2) It does not require the associations of independent pre-assembled RC complexes 
3) A CI intermediate acts as a scaffold for the incorporation of free CIII+CIV subunits  
4) Respirasomes are the structural units where CI is fully-assembled and activated 
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INTRODUCTION 
 The mammalian oxidative phosphorylation (OXPHOS) system is formed by five 
multiprotein enzyme complexes and two mobile electron carriers (ubiquinone and 
cytochrome c) embedded in the mitochondrial inner membrane. Complexes I to IV (CI 
to CIV) form the respiratory chain (RC), which facilitates electron transfer from 
reducing equivalents to molecular oxygen coupled to proton pumping across the inner 
membrane. The proton gradient generated is subsequently used by complex V to drive 
ATP synthesis. With the exception of CII subunits that are all encoded by the nuclear 
genome, the remaining OXPHOS enzymes contain subunits of dual genetic origin, 
nuclear and mitochondrial. Nuclear DNA (nDNA)-encoded subunits are synthesized on 
cytosolic ribosomes and imported into mitochondria, where they assemble together with 
mitochondrial DNA (mtDNA)-encoded subunits and prosthetic groups to build up 
OXPHOS complexes with the assistance of specific chaperones or assembly factors 
(Fernandez-Vizarra et al., 2009).  
 The structural and functional organization of the respiratory chain has been a 
matter of debate over more than 50 years. Two models have been historically 
hypothesized. Following the “fluid state” model, individual OXPHOS complexes 
diffuse freely in the mitochondrial inner membrane and electron transport occurs when 
the complexes randomly collide (Hackenbrock et al 1986). Conversely, the “solid state” 
model proposes that OXPHOS complexes are organized in rigid higher order assemblies 
(Chance and Williams, 1955) known as supercomplexes or respirasomes (Schagger and 
Pfeiffer, 2000). It is currently accepted that both organizations probably coexist, giving 
rise to the “dynamic aggregate” or “plasticity” model. This model suggests that 
OXPHOS complexes switch from freely moving to fixed structures and viceversa to 
adapt to changes in cellular metabolism (Acin-Perez et al., 2008). Accordingly, the 
coexistence of the respirasome unit, composed of at least CI+CIII+CIV, together with 
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free CIII and CIV has been widely described (Althoff et al., 2011; Dudkina et al., 2011; 
Heinemeyer et al., 2007; Schafer et al., 2006; Schagger and Pfeiffer, 2000). However, 
the association of complexes II and V with the respirasomes remains controversial 
(Acin-Perez et al., 2008; Wittig and Schagger, 2009). It has been suggested that 
association of RC complexes in respirasomes may offer structural or functional 
advantages, such as the prevention of their destabilization and degradation, the 
enhancement of electron transport efficiency and substrate channeling, or the decrease 
of electron or proton leakages (Lenaz and Genova, 2010). As a consequence of their 
organization in supercomplexes, a structural interdependence exists amongst the 
individual OXPHOS complexes (Acin-Perez et al., 2004; Diaz et al., 2006; Li et al., 
2007; Schagger et al., 2004; Soto et al., 2009). This has major biological as well as 
biomedical implications, since RC enzyme assembly defects produce severe 
encephalomyopathies and neurodegenerative disorders in human and have been 
associated with the aging process. In human mitochondrial diseases, structural 
alterations primarily affecting one given complex often induce pleiotropic deleterious 
effects of the other enzymes. For instance, pathogenic mutations in CIII subunits or 
assembly genes lead to pleiotropic deficiencies of CI and CIV in affected tissues 
(Fernandez-Vizarra et al., 2007; Lamantea et al., 2002; Moran et al., 2010), mutations in 
CIV subunits may lead to secondary CI deficiencies (D'Aurelio et al., 2006) and 
mutations affecting CI-specific genes can produce combined CI and CIII, or CI and 
CIV, deficiencies in patients (Budde et al., 2000; Saada et al., 2011).  
 The mechanisms that regulate the biosynthesis of mitochondrial supercomplexes 
remain unsolved. Pulse-chase experiments that analyzed the time-course incorporation 
of the thirteen mtDNA-encoded proteins into RC complexes and supercomplexes 
suggested that the latter originate by the direct association of single pre-assembled 
complexes (Acin-Perez et al., 2008). However, the observation that in the absence of 
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monomeric holo-CIV newly-imported nDNA-encoded CIV subunits were preferentially 
integrated into supercomplexes, suggested that the formation of these macromolecular 
assemblies does not necessarily require the preassembly of individual holocomplexes, 
but could also be achieved through a coordinated association of partially-assembled 
complexes and free subunits (Lazarou et al., 2009).  
In the present study we have addressed the biosynthetic pathway of 
mitochondrial RC supercomplexes by partially depleting control cell lines of OXPHOS 
complexes by treatment with doxycycline, a reversible inhibitor of mitochondrial 
translation. The synthesis of mtDNA-encoded subunits resumed after drug removal, and 
we subsequently investigated their time-course incorporation into supercomplex 
assembly intermediates. Based on the analyses of the composition and function of these 
intermediates we propose a multistep model for mitochondrial supercomplex assembly. 
It involves three sequential basic steps: 1-formation of a CI assembly intermediate; 2- 
incorporation of CIII and CIV subunits and subassemblies; 3- final assembly of CI by 
incorporation of the NADH dehydrogenase catalytic core and subsequent functional 
respirasome activation. This model allows us to explain the requirements for CI 
assembly, the structural interdependences among OXPHOS complexes, and why certain 
genetic defects affecting a single complex may lead to combined RC enzyme defects in 
patients. 
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RESULTS 
Distribution of RC subunits in mitochondrial complexes and supercomplexes 
We analyzed the relative distribution of individual RC subunits between large 
supercomplexes I+III2+IVn (SC), small supercomplexes (III2+IV), and free RC 
complexes I (CI), III (CIII2), and IV (CIV) in three common human control cell lines 
(143B206 osteosarcoma cells, HEK293 embryonic kidney cells and control 
transmitochondrial cybrids). Blue native gel electrophoresis (2D-BN/SDS-PAGE) in 
combination with western-blot analysis showed comparable protein contents and 
distribution patterns of all tested RC subunits in the three control cell lines (Figure 1). 
Between 65-97% of the signals corresponding to CI subunits were localized in 
supercomplexes larger than  ̴1500 kDa (SC). The NDUFA9 and NDUFS2 subunits also 
colocalized in a spot (indicated as CI*) that corresponds to a stable  ̴ 830 kDa 
subcomplex. The NDUFA9, NDUFS2 and NDUFS4 subunits were additionally 
detected at reduced levels in lower bands that resemble the previously reported pattern 
of CI subcomplexes (Antonicka et al., 2003; Lazarou et al., 2007; Ugalde et al., 2004a; 
Vogel et al., 2007a). Concerning CIII subunits, ~50% of CORE2 and Rieske Iron 
Sulphur Protein (RISP) were detected in large I+III2+IVn supercomplexes, ̴ 40% in free 
CIII homodimers, and  ̴ 5-10% in supercomplex III2+IV. In contrast,  ̴ 30% of the 
signals corresponding to the CIV COX1 and COX5A subunits was detected in 
I+III2+IVn supercomplexes, ̴ 65-70% in free holo-CIV, and only traces ( ̴ 1-3%) in 
supercomplex III2+IV. The signal corresponding to the SDHA subunit appeared mainly 
at the complex II position (CII), with no clear colocalization with supercomplexes. 
These results are comparable to those reported in other mammalian cell lines or tissues 
(Schagger and Pfeiffer, 2001). The signals obtained from three independent western-
blots per cell line were quantified and expressed as percentages of the total signal 
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obtained from each antibody (Table S1).The CIII RISP and CIV COX1 subunits were  
̴50% less abundant within supercomplex III2+IV than their respective partners CORE2 
and COX5A. Likewise, the RISP subunit was  ̴ 20% less abundant than CORE2 within 
supercomplex I+III2+IVn, whereas COX1 was  ̴ 25% more abundant than COX5A. 
These results suggest stoichiometric variations among RC subunits of the same complex 
within the different supercomplex forms.  
 
Effects of doxycycline treatment in mitochondrial translation and RC assembly 
These variations in the distribution patterns of subunits from the same RC 
complex could be explained by differences in either the assembly kinetics or the 
stability of these subunits within the supercomplexes. To discriminate between these 
two possibilities, we depleted cells of mtDNA-encoded subunits-containing OXPHOS 
complexes and supercomplexes by treating the cultures with doxycycline, a reversible 
inhibitor of mitochondrial translation. This strategy was successfully used to follow the 
assembly kinetics of CI (Ugalde et al., 2004a; Pello et al., 2008). We cultured the 143B 
cells and control cybrids for 6 days, and the HEK293 cells for 8 days in the presence of 
15µg/ml doxycycline. Longer treatments affected cell viability (Ugalde et al., 2004a). 
Real-time PCR analyses showed that doxycycline induced a partial loss (35-40%) of 
mtDNA molecules, which recovered back to normal levels 96 h after the treatment. 
Additionally, doxycycline severely inhibited mitochondrial protein synthesis in 143B 
cells without affecting overall cytoplasmic translation, although a 10-15% residual 
synthesis of mitochondrial polypeptides was detectable after quantification (Figure S1). 
The sporadic mtDNA loss did not further affect mitochondrial translation, since the 
expression of mitochondrial polypeptides recovered normal levels 72 h after 
doxycycline treatment. 
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To follow the accumulation of newly-synthesized RC complexes and their 
further association into supercomplexes, samples were collected at different time points 
(0, 6, 15, 24, 48, 72 and 96 hours) after doxycycline removal. Digitonin-solubilized 
mitochondrial particles were separated by BN-PAGE and analyzed by western-blot. In 
agreement with the residual synthesis of mtDNA-encoded subunits, we detected an  ̴ 
80% reduction of CIII and CIV, and a lack of fully-assembled CI (see 0h, Figure S2). 
These residual amounts were not sufficient to sustain the formation of supercomplexes, 
in agreement with previous studies suggesting that respirasome assembly proceeds 
when individual complexes III and IV have accumulated above a critical threshold 
(D'Aurelio et al., 2006). CII levels were normal after doxycycline treatment, as expected 
since this complex lacks mtDNA-encoded subunits.  
 
Assembly kinetics of complex I subunits in mitochondrial supercomplexes 
Mammalian CI biogenesis consists in a semi-sequential pathway that involves 
the preassembly and further association of evolutionarily conserved functional modules 
(Ugalde et al., 2004a). To follow CI assembly and incorporation into supercomplexes, 
samples from doxycycline treatment-recovery experiments were separated by 2D-
BN/SDS-PAGE and blots were probed with antibodies that recognize subunits 
representative of different CI assembly stages (McKenzie and Ryan, 2010). NDUFS2 is 
an early-assembly subunit that forms subcomplexes of the peripheral arm ubiquinone 
reduction (or Q) module; NDUFA9 is an intermediate-assembly subunit that is thought 
to be located in the boundary between the peripheral arm and the hydrophobic 
membrane arm (or P module); and NDUFV1 and NDUFS4 are constituents of the 
peripheral arm NADH dehydrogenase (or N) catalytic module that are crucial to the 
final steps of CI assembly. After 6 days of doxycycline treatment (0h in Figure 2A), we 
did not detect any of the tested CI subunits within the I+III2+IVn supercomplex. At this 
                                                                                                                                Moreno-Lastres et al.  10 
time, residual amounts of NDUFA9 and NDUFS2 accumulated in spots previously 
reported as CI subassemblies (Ugalde et al., 2004a; Vogel et al., 2007a). One common 
spot (indicated as CI*) corresponded to the stable subcomplex of  ̴ 830 kDa that lacked 
the NDUFS4 and NDUFV1 subunits, both of which are part of the CI N module. This 
subcomplex constitutes a physiological CI assembly intermediate that accumulates in 
cells from patients with pathogenic mutations in the NDUFS1, NDUFS4 and NDUFV1 
genes (Hoefs et al., 2010; Lazarou et al., 2007; Ugalde et al., 2004b; Vogel et al., 
2007b). As the translation of mitochondrial proteins restarted, the CI* subcomplex 
moved towards the position of the large I+III2 or I+III2+IVn supercomplexes and 
disappeared  ̴ 72-96 h after doxycycline removal, indicating that it could be a 
supercomplex assembly intermediate. Accumulation of the NDUFA9 and NDUFS2 
proteins in supercomplexes started to be detected around 15-24 h after doxycycline 
removal and reached maximum levels at time 96 h. However, the NDUFS4 and 
NDUFV1 subunits appeared in such structures between 48-72 h after removing the 
drug, indicating that the initial incorporations of these two subunits within the 
supercomplexes were delayed in comparison with the NDUFA9 and NDUFS2 subunits. 
These data suggest that at early supercomplex assembly stages CI is neither fully-
assembled nor active when it binds to other RC complexes, since it lacks part of the N 
module catalytic subunits. The NDUFS4 subunit reached its maximum steady-state 
levels at time 96 h, indicating that despite of its initial delay this subunit gets rapidly 
integrated into supercomplexes. However, the NDUFV1 subunit showed much lower 
levels at 96 h, indicating a marked delay in its incorporation into supercomplexes. A 
quantitative estimation of the assembly rates for the different CI subunits is shown in 
Figure 2B. 
 
Assembly kinetics of complex III subunits in mitochondrial supercomplexes 
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 Although CIII assembly has not been well studied in mammals, a model for the 
biosynthetic pathway of this complex has been proposed in yeast (Zara et al., 2009). 
Based on this model, we analyzed the integration into CIII of an early-assembly 
accessory subunit (CORE2), and a late-assembly catalytic subunit (RISP) and their 
further incorporations into the native supercomplex species III2+IV, I+III2 and 
I+III2+IVn (the latter two indicated as SC in Figure 3A, B and C). After 6 days of 
doxycycline treatment (0h), we observed an  ̴ 80-90% reduction in the amounts of 
CORE2 and RISP subunits within the CIII dimer (CIII2) compared to untreated cells 
(SS in Figure 3B). The accumulation of both subunits within CIII2 increased gradually 
after the translation of mtDNA-encoded proteins resumed; the CORE2 protein reached 
maximum steady-state levels after 24-48 h, and the RISP subunit did it after 72-96 h. 
These data confirmed that in human cells, the RISP subunit also gets assembled at a late 
stage of CIII assembly. Low levels of the CORE2 protein appeared in the III2+IV and 
I+III2+IVn supercomplexes around 24-48 h after doxycycline removal, reaching its 
maximum steady-state levels at 96 h (Figures 3 and S3A). The incorporation of RISP 
within the I+III2+IVn supercomplexes was delayed compared to CORE2, since it 
appeared ~48 h after doxycycline removal, keeping low levels ( ̴ 30-50% of the steady-
state) after 96 h. These data indicate that at early supercomplex assembly stages CIII is 
neither fully-assembled nor active, since it lacks at least the RISP subunit. Surprisingly, 
RISP started appearing within the III2+IV supercomplex at time 96 h, suggesting that 
the III2+IV supercomplex gets fully-assembled after the formation of the I+III2+IVn 
supercomplexes.  
 
Assembly kinetics of complex IV subunits in mitochondrial supercomplexes 
 We next analyzed the incorporation of four subunits involved in early steps of 
human CIV assembly (two mtDNA-encoded catalytic subunits, COX1 and COX2, and 
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two nDNA-encoded structural subunits, COX4 and COX5A) and that of a late-assembly 
structural subunit (COX6C) into holo-CIV, and into the III2+IV and I+III2+IVn 
supercomplexes (Fornuskova et al., 2010; Nijtmans et al., 1998)(Figure 4A). The 
quantification of CIV signals from BN experiments showed that after 6 days of 
doxycycline treatment (0h), there was a ̴ 90% reduction in the amounts of all COX 
subunits within holo-CIV compared with the untreated cells (SS) (Figure 4B). The 
incorporation rates of all subunits within CIV increased steadily after restarting 
mitochondrial translation and reached maximum steady-state levels at least after 96 h 
following doxycycline removal. These data confirmed our previous results suggesting 
that in control human cells, fully-assembled CIV is restored later than CI and CIII (Pello 
et al., 2008). The COX4 and COX5A subunits started getting incorporated into the 
I+III2+IVn and III2+IV supercomplexes 24-48 h after doxycycline removal (Figure 4 
and S3B). In contrast, the COX1, COX2 and COX6C subunits appeared in the 
I+III2+IVn supercomplexes after 48-72 h, indicating a delayed incorporation of these 
three subunits in the large supercomplexes. As shown in Figure 4B, these subunits 
followed different incorporation rates into I+III2+IVn supercomplexes, since COX2 
steady-state levels were fully-restored 96 h after doxycycline removal, while COX1 and 
COX6C levels remained low ( ̴ 40-50% of the steady-state). The COX1, COX2 and 
COX6C subunits were first detected in the III2+IV supercomplex at time 96 h. As for 
CIII, these data indicate that CIV is neither fully-assembled nor active when its subunits 
and intermediates bind other RC complexes to form supercomplexes, and confirm that 
the biosynthesis of the I+III2+IVn supercomplexes precedes the formation of the III2+IV 
supercomplex.  
 
Assembly kinetics of RC subunits into mitochondrial supercomplexes 
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 To obtain a comprehensive view of the supercomplex assembly pathway, we 
performed a comparative analysis of the incorporation rates of all tested RC subunits 
into the large I+III2+IVn supercomplexes (Figure 5 and S3C). Our results showed that 
CI NDUFA9 and NDUFS2 subunits were initially stabilized in a CI subassembly (CI*, 
Figure 2) lacking the catalytic N module, which constitutes the first supercomplex 
assembly intermediate (SC1). In BN gels, this intermediate started moving towards the 
position of the I+III2+IVn supercomplexes around 24 h after doxycycline removal, in 
parallel with the incorporation of CIII CORE2 subunit and CIV COX4 and COX5A 
subunits, reaching maximum levels at time 96 h (Figure S3C). These data imply the 
formation of a second supercomplex assembly intermediate (SC2) composed of 
partially-assembled CI with incorporated CIII and CIV subunits or subassemblies 
(Figure 5A). The CI NDUFS4 and CIV COX2 subunits first appeared in I+III2+IVn 
supercomplexes around 48 h after removing the drug, but rapidly reached their 
maximum levels. These data indicate that the incorporation of these two RC subunits 
within the large supercomplexes occurs in a third assembly stage (SC3). The catalytic 
CIII RISP and CIV COX1 subunits, and the structural CIV subunit COX6C appeared at 
low levels in I+III2+IVn supercomplexes after 48-72 h, but these levels remained low at 
time 96 h, indicating a slower incorporation of these three subunits in a fourth 
supercomplex assembly stage (SC4). Due to the low relative abundance of COX1 and 
COX6C within supercomplexes at time 96 h, we cannot differentiate which of these two 
CIV subunits gets inserted first. This is compatible with a model in which COX1 could 
get assembled before the final bulk of COX subunits to complete the supercomplex 
structures. Finally, the catalytic CI subunit NDUFV1 started appearing in I+III2+IVn 
supercomplexes after 48-72 h, but its assembly kinetics were markedly slower than that 
of the RISP, COX1 and COX6C subunits, indicating that NDUFV1 incorporates into 
supercomplexes in a fifth assembly stage (SC5). 
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 Based on these results, RC supercomplexes should get activated in parallel with 
the incorporation of the last catalytic subunits (between 48-72 h after doxycycline 
removal). To confirm this hypothesis, we analyzed samples by BN-PAGE followed by 
CI and CIV in-gel activity (IGA) assays (Figure 5B). After 6 days of doxycycline 
treatment (Figure 5B, 0h), we observed a virtual absence of CI and CIV activities 
within supercomplexes (indicated as SCa) compared to untreated cells (SS, Figure 5B). 
Densitometric analyses of the IGA assays (Figure 5C) showed that the enzymatic 
activities of both complexes started increasing gradually in supercomplexes ~48 h after 
doxycycline removal without reaching their maximum activities after 96 h, in parallel 
with the incorporation of the NDUFV1 and COX1 subunits. This result was confirmed 
by spectrophotometric measurements of rotenone-sensitive CI NADH dehydrogenase 
activity (Figure 5D).  
 
Altered assembly of mitochondrial supercomplexes in COX2 mutant cybrids 
 To verify our supercomplex assembly model, we investigated the effect of 
pathogenic mutations that affect the assembly of single RC complexes in the formation 
of supercomplexes. We analyzed a 143B mutant cybrid carrying the homoplasmic 
m.7896 G>A mutation in the COX2 gene, described in a CIV-deficient patient (Campos 
et al., 2001). BN-IGA assays showed severe reductions of CI and CIV enzyme activities 
in the mutant cybrids compared to an isogenic control (Figure 6A). Western-blot 
analyses of duplicate BN gels showed the mutants lack fully-assembled CIV and COX-
containing supercomplexes, although they accumulate the I+III2 supercomplex and CIII 
dimer (CIII2) (Figure 6A). Analyses by the sensitive 2D-BN/SDS-PAGE method 
confirmed that  mutant cybrids (M in Figure 6B) completely lack holo-CIV due to the 
absence of COX2, as a consequence of which, most of the remainder CIV subunits were 
presumably degraded and those detected accumulated as monomers or small CIV 
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assembly intermediates. This lack of CIV led to the absence of I+III2+IVn and III2+IV 
supercomplexes, and an accumulation of CIII2, the I+III2 supercomplex, and the  ̴830 
kDa supercomplex assembly intermediate (CI* or SC1). We observed a severe 
reduction of the NDUFS4 and NDUFV1 subunits within the I+III2 supercomplex, in 
contrast with the relative abundance of other CI subunits such as NDUFA9 or NDUFS2 
(Figure 6B). These results suggest that in the absence of CIV most I+III2 supercomplex 
is probably partially-assembled and inactive due to a hampered assembly or stability of 
the NDUFS4 and NDUFV1 subunits. At longer exposures (Figure S4A) the COX1 and 
COX4 subunits were detected at low levels in the I+III2 supercomplex, although the 
COX5A and COX6C subunits were not so clearly distinguished. These data suggest that 
certain free COX subunits or subassemblies may bind directly to supercomplex 
intermediates in the absence of holo-CIV, as previously proposed (Lazarou et al., 2009).  
 The steady-state levels of CII were similar in COX2 mutant and control cells, 
and did not colocalize with supercomplexes (Figure 6). After long exposures, CII traces 
were detected in a high supramolecular structure that could represent a supercomplex 
(Figure S4B). However, the abundance and electrophoretic mobility of this particular 
spot (indicated as SCII) was unaffected by the lack of CIV in the mutant cell line. This 
result argues against CII being a functional constituent of human I+III2+IVn 
supercomplexes. 
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DISCUSSION 
We aimed to elucidate the biosynthetic pathway of mitochondrial 
supercomplexes, to better understand the molecular mechanisms underlying the 
interdependence between RC complexes that would aid explaining the severe RC 
assembly defects found in patients with mitochondrial disorders. To address the 
dynamics of assembly, we depleted control cell lines of OXPHOS complexes by 
treatment with doxycycline to reversibly inhibit mitochondrial translation, and upon 
drug removal we followed complex and supercomplex assembly by BN-PAGE and 
immunodetection. Based on the analyses of the assembly kinetics of OXPHOS subunits, 
we propose a multi-step model of mitochondrial supercomplex assembly (Figure 7). 
The conceptual novelty of this model is that the biogenesis of the respirasome involves 
the coordinated and sequential association of specific combinations of partially-
assembled RC complexes and free subunits. In a first stage, CIII and CIV assemble as 
individual entities until reaching a threshold supposed to trigger the accumulation of 
free subunits and assembly intermediates from these two complexes. At this early stage, 
the assembly of CI probably also starts taking place, in agreement with reports 
demonstrating that the assembly of CI and CIII launch in parallel (Pello et al., 2008), 
until building up a CI intermediate of  ̴830 kDa that lacks the NADH dehydrogenase 
module and perhaps additional subunits. Up to this stage, the pattern of CI 
subcomplexes is in agreement with previous reports (Antonicka et al., 2003; Lazarou et 
al., 2007; Ugalde et al., 2004a; Vogel et al., 2007a). We propose that the  ̴830 kDa CI 
subassembly actually constitutes the first supercomplex assembly intermediate (SC1), 
since it remains in a stable competent state for the subsequent combined incorporation 
of either individual subunits or subassemblies from CI, CIII and CIV in at least five 
sequential assembly steps (SC1 to SC5 in Figure 7). The latest supercomplex assembly 
step involves the association of catalytic subunits from the CI NADH dehydrogenase 
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module prior to the respirasome activation cascade, although we cannot exclude 
additional intermediate steps between these two events. Our results not only imply that 
SC1 is the core structure necessary for the formation of the respirasomes, but also that 
the respirasomes constitute the structural units where CI gets fully-assembled and 
activated, thus explaining the essentiality of the respirasomes for CI function (Schagger 
et al., 2004).  
The mechanism we propose contrasts with the previously suggested pathway 
based on the association of individual fully-assembled RC complexes (Acin-Perez et al., 
2008). To demonstrate their hypothesis, the authors analyzed the time course 
incorporation of the13 mtDNA-encoded OXPHOS proteins into RC complexes and 
supercomplexes by BN-PAGE, convincingly showing that there is a temporal gap 
between the incorporation of mtDNA-encoded subunits into the individual complexes 
and that into supercomplexes. Our results agree with this observation, but the additional 
analyses of nuclear-encoded OXPHOS subunits provided here do not support the 
interpretation that supercomplexes are formed by the ordered association of 
preassembled complexes. The faster kinetics of assembly of supercomplexes under their 
conditions is probably due to the fact that a large pool of translated RC subunits already 
exists in preassembled subcomplexes and supercomplex intermediates (Fernandez-
Vizarra et al., 2009), which remain in a competent state for the efficient channeling of 
newly translated mtDNA-encoded subunits into assembly intermediates and 
subsequently in RC complexes or supercomplexes. In our supercomplex assembly 
model, the biogenesis of CIII and CIV take place prior to the formation of CI, which 
can only occur in the context of the respirasome. In this regard, our model does not 
contradict the plasticity model, since it does not exclude the assembly of holo-CIII and 
CIV as independent pathways, but it excludes the formation of fully-assembled CI as an 
independent unit. Rather, we propose that there are at least two regulatory steps in the 
                                                                                                                                Moreno-Lastres et al.  18 
biogenesis of the OXPHOS system: first, the independent regulation of the assembly of 
individual holo- CIII and CIV, and second, the association of free CIII and CIV 
subunits or subassemblies with a CI assembly intermediate to form the respirasome. 
There must be additional regulatory steps, since the functional meaning of intermediate 
supercomplex forms remains unknown and deserve future attention. For example, 
supercomplexes I+III2 or III2+IV could constitute either intermediate structures that 
would aid the assembly of newly-synthesized supercomplexes to adapt to changes in 
cellular metabolism or maybe just supercomplex degradation products.  
The current available literature regarding OXPHOS-deficient patients and 
animal models support the key steps of our respirasome assembly model. It was 
described in human primary fibroblasts that the 830 kDa CI intermediate (SC1) contains 
most CI subunits, but neither NDUFS4 nor the subunits from the N catalytic module 
(Lazarou et al., 2007). In agreement, the 830 kDa intermediate is usually accumulated in 
patients´ fibroblasts with mutations in the CI NDUFS4 subunit (or mice lacking this 
subunit) or in subunits from the N catalytic module, such as NDUFS1 or NDUFS6 
(Calvaruso et al., 2011; Hoefs et al., 2010; Kirby et al., 2004; Ugalde et al., 2004b). 
More importantly, this 830 kDa subassembly has been found associated with CIII 
subunits CORE1 and CORE2 in partially-assembled supercomplexes from patients´ 
cells and mutant mice tissues (Calvaruso et al., 2011; Lazarou et al., 2007). Tissues 
from patients harboring mutations in the BCS1L gene, involved in the assembly of the 
RISP subunit into CIII, revealed the accumulation of the CORE proteins in high-
molecular-weight respirasome intermediates that lacked the RISP protein in mutant but 
not in wild-type cells, suggesting that these subunits could get assembled into 
supercomplexes prior to the incorporation of RISP (Fernandez-Vizarra et al., 2009). 
Mitochondria from patients in whom CIV biogenesis was compromised displayed a 
preferential accumulation of certain CIV subunits in supercomplexes (Lazarou et al., 
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2009), as observed in our COX2 mutant cybrids. These similarities between human and 
mice primary cell cultures or tissues and the established cell lines shown in our work 
support the generality in mammals of the respirasome assembly mechanisms that we 
propose. 
Our results concerning the composition of mitochondrial supercomplexes in 
human control cell lines agree with previous observations in other mammalian systems. 
Approximately 90% of CI is associated with a CIII dimer (CIII2) and several CIV units 
to form two major supercomplexes: I+III2 and I+III2+IV1-4 (Schagger and Pfeiffer, 
2001). In contrast, ~50-60% of CIII and 70-80% of CIV remain individual, although 
both dynamically interact in an intermediate III2+IV supercomplex. Incidentally, our 
data do not support CII colocalization with mitochondrial supercomplexes. Tiny 
amounts of CII that migrated as a smear up to 400 kDa, below the CIII2 position, could 
correspond to CII trimers as shown in bacteria (Sousa et al., 2011). Another tiny spot 
detected in a supramolecular structure above supercomplex I+III2+IVn could represent 
CII as a component of the mitoKATP channel (Ardehali et al., 2004).  None of these 
spots clearly colocalized with any RC complexes or supercomplexes. This is in 
disagreement with a previous study based on co-IP and BN analyses and the same 
experimental conditions used here, which claimed binding of some CII to 
supercomplexes (Acin-Perez et al., 2008). These discrepancies could be due to technical 
differences in the tissue-specific mitochondrial protein extraction methods or the 
electrophoretic conditions used, which could affect the mobility of the samples. 
However, most studies using techniques as diverse as BN-PAGE, single particle 
electron microscopy, cryoelectron tomography, flux control analyses, or studies based 
on time-dependent localization of fluorescent RC subunits failed to show structural or 
functional evidences supporting the presence of CII in mammalian RC supercomplexes 
in normal physiological conditions (Dudkina et al., 2011; Lenaz and Genova, 2010; 
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Muster et al., 2010; Quarato et al., 2011; Schafer et al., 2006; Schagger and Pfeiffer, 
2000, 2001).  
Importantly, our respirasome assembly model may explain why certain genetic 
defects affecting a single complex lead to combined RC enzyme deficiencies in patients. 
For instance, it explains why CIV deficiences due to mutations in COX1 and COX2 
lead to pleiotropic CI defects (this work and D'Aurelio et al., 2006). The insertions of 
these two CIV subunits into supercomplexes occur prior or in parallel with the 
incorporation of subunits from the CI N catalytic module (NDUFV1 and NDUFS4). 
Consequently, the lack of COX1/COX2 or the total absence of holo-CIV affects the 
assembly or stability of NDUFS4 and NDUFV1 within supercomplexes. This in turn 
leads to the accumulation of the inactive  ̴ 830 kDa supercomplex assembly intermediate 
and a I+III2 intermediate that partially lacks the CI N catalytic module, thus explaining 
the severe reduction in CI activity detected in the COX mutant cells. A similar assembly 
phenotype has been recently described in NDUFS4 knock-out mice (Calvaruso et al., 
2011). The same argument serves to explain why failures in the insertion of the CIII 
subunit RISP may lead to secondary CI and CIV deficiencies in human tissues 
(Fernandez-Vizarra et al., 2007; Moran et al., 2010).  
The fact that CIII and CIV can get assembled either as individual holoenzymes 
or by direct binding of free subunits to supercomplex assembly intermediates supports 
the existence of several independently-regulated assembly pathways for the biosynthesis 
of these two complexes. This would explain why decreased CI levels do not usually 
lead to CIII and CIV assembly and functional defects in mammals (Acin-Perez et al., 
2004; Schagger et al., 2004). Exceptions have been described in CI-deficient patients 
with mutations in the NDUFS4 subunit (Budde et al., 2000; Ugalde et al., 2004b) and 
C20ORF7 (Saada et al., 2011), a mitochondrial methyltransferase involved in the 
assembly or stability of an early CI assembly intermediate (Sugiana et al., 2008). While 
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the reason remains unclear, the possibility exists that the CIII and CIV deficiencies 
observed in these patients could be secondary phenomena. Alternatively, NDUFS4 
could function in the assembly or stability of individual CIII, besides its role in 
supercomplex biogenesis. Similarly, C20ORF7 could participate in the assembly or 
stability of monomeric CIV, as well as in the post transcriptional modification of 
proteins important for respirasome structural stability. In this regard, C20ORF7 has 
been suggested to play a role in the methylation of CI subunit NDUFB3, and it could 
potentially modify additional OXPHOS components (Sugiana et al., 2008). 
Our model indirectly clarifies the possible roles of known chaperones in the 
assembly of RC supercomplexes. The most evident case is the NDUFAF2 (B17.2L) 
assembly factor, which appears to function in a late stage of CI assembly. This protein 
binds to the ~830 kDa subcomplex and participates in the insertion of the N module into 
CI (Ogilvie et al., 2005; Vogel et al., 2007b). Because the ~830 kDa subcomplex is a 
supercomplex assembly intermediate, and the insertion of the N module is one of the 
last steps in the respirasome assembly pathway, it seems appropriate to consider 
NDUFAF2 as the first known supercomplex assembly factor. The roles of other 
chaperones involved in late steps of CI assembly, or assembly factors that regulate the 
biosynthesis of RC CIII and CIV could be also redefined within the frame of the 
supercomplex assembly pathway described here. 
Additional work is required to explain in detail the assembly of all OXPHOS 
subunits into respirasomes, identify the mechanisms that regulate the diverse 
biosynthetic pathways for the formation of RC complexes and supercomplexes, and 
their modulation in response to environmental and physiological conditions. 
Nonetheless, our model for supercomplexes assembly represents a starting point to 
further elucidate this intricate process, and provides a framework to better understand 
RC assembly defects in patients with mitochondrial disorders. 
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EXPERIMENTAL PROCEDURES 
Cell lines and culture conditions 
Cybrids were constructed using the osteosarcoma 143B TK-206 rho zero cell line and 
enucleated control fibroblasts as described (King and Attardi, 1989). Cells were 
cultured in high-glucose Dulbecco’s modified Eagle medium (DMEM, Life 
Technologies) supplemented with 10% fetal calf serum (FCS), 2 mM L-glutamine, 
1mM sodium pyruvate and antibiotics. To block mitochondrial translation, 15 µg/ml 
doxycycline was added to the culture medium. Cells were grown in exponential 
conditions and harvested at the indicated time points.  
Quantification of mtDNA copy number 
The relative quantification of mtDNA versus nuclear DNA (nDNA) was performed by 
real-time PCR in a HT 7500 Real Time PCR System (Applied Biosystems) as 
previously described (Pello et al., 2008). 
Mitochondrial protein preparation 
Mitochondrial pellets were isolated from cell cultures as described (Pello et al., 2008). 
To prepare native mitochondrial proteins, pellets were solubilized in 200 µl buffer 
containing 1.5 M aminocaproic acid, 50 mM Bis-Tris, pH 7.0. After optimizing 
solubilization conditions, we decided to use digitonin at a concentration of 4 g/g protein. 
Solubilized samples were incubated on ice for 15 min, centrifuged for 30 min at 13000 
rpm at 4ºC, and the supernatant was combined with 20 µl of sample buffer (750mM 
aminocaproic acid, 50mM Bis-Tris, 0.5mM EDTA, 5% Serva Blue G-250) prior to 
loading.  
Blue Native electrophoresis and in-gel activity assays  
Blue Native 3-13% gradient gels were loaded with 60 µg of mitochondrial protein and 
processed as described (Nijtmans et al., 2002). After electrophoresis, proteins were 
transferred to a PROTAN® nitrocellulose membrane (Schleicher & Schuell) at 35 V, 
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overnight, and probed with specific antibodies. Duplicate gels were further used for in-
gel enzyme activity (IGA) assays and for second dimension 10% SDS-PAGE gels.  
Antibodies 
Western-blot was performed using primary antibodies raised against the following 
human OXPHOS subunits: NDUFV1 (Sigma), NDUFA9, NDUFS2, NDUFS4, CORE2, 
RISP, COX1, COX2, COX4, COX5A, COX6C and SDHA (Mitosciences). Peroxidase-
conjugated anti-mouse IgG was used as a secondary antibody (Molecular Probes). The 
signal was detected with ECL® plus (Amersham Biosciences). 
Spectrophotometric assays 
Rotenone-sensitive CI (NADH: ubiquinone oxidoreductase) activity was measured with 
a DU-650 spectrophotometer (Beckman) at 37°C by incubating 150 µg of mitochondrial 
protein in 1 ml of assay medium (20 mM KP pH 8.0, 0.1 % BSA-EDTA, 100 µM 
CoQ1, 1 mM NaN3, 0.2 mM NADH without and with 5 µM rotenone). The absorbance 
decrease at 340 nm due to the NADH oxidation was measured, and expressed as the 
percentage relative to the citrate synthase activity.  
Statistical analysis 
Densitometry was performed with the ImagePro-Plus 4.1 image analysis software 
(Media Cybernetics). Graphs represent mean values of at least three independent 
measurements. Error bars represent standard deviations (SD).  
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FIGURE LEGENDS 
Figure 1. Steady-state levels of mitochondrial supercomplexes in human cell lines.  
Sixty µg of isolated mitochondria were analyzed by 2D-BN/SDS-PAGE. Western-blot 
analysis was performed using antibodies against the indicated OXPHOS subunits. SC, 
supercomplexes containing CI, CIII and CIV. CI*, partially-assembled CI. CIII2, 
complex III dimer. CIV*, putative CIV dimer. III2+IV, supercomplex containing CIII 
and CIV. See also Table S1 and Figures S1 and S2.  
Figure 2. Incorporation rates of individual complex I subunits in supercomplexes. 
(A) Example of 2D-BN/SDS-PAGE western blot analysis in doxycycline-treated 143B 
cells using antibodies against the indicated CI subunits. (B) Mean incorporation rates of 
CI subunits in large supercomplexes (SC). The signals corresponding to CI subunits 
were quantified in duplicate gels per cell line, and normalized by the CII SDHA 
subunit. (a.d.u.), arbitrary densitometric units. Mean values are expressed as percentages 
relative to untreated cells (SS). Error bars represent standard deviations (SD). 
Abbreviations as in Figure 1. See also Figure S3. 
Figure 3. Assembly kinetics of individual complex III subunits in supercomplexes. 
(A) Example of 2D-BN/SDS-PAGE western blot analysis in doxycycline-treated 143B 
cells using antibodies against the indicated CIII subunits. (B) Densitometric histogram 
representing the assembly progress of the CORE2 and RISP subunits in CIII-containing 
structures. (C) Mean incorporation rates of CORE2 and RISP subunits in CIII-
containing structures. The signals were quantified in duplicate gels per cell line, and 
normalized by CII. CIII2, complex III dimer (left panel); III2+IV, supercomplex 
containing CIII and CIV (middle panel); SC, supercomplexes containing CI, CIII and 
CIV (right panel). (a.d.u.), arbitrary densitometric units. Mean values are expressed as 
percentages relative to untreated cells (SS). Error bars represent standard deviations 
(SD). See also Figure S3. 
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Figure 4.  Assembly kinetics of individual complex IV subunits in supercomplexes. 
(A) Example of 2D-BN/SDS-PAGE western blot analysis in doxycycline-treated 143B 
cells using antibodies against the indicated CIV subunits. (B) Mean incorporation rates 
of CIV subunits in CIV-containing structures. The signals were quantified in duplicate 
gels per cell line, and normalized by CII. CIV, complex IV (left panel); III2+IV, 
supercomplex containing CIII and CIV (middle panel); SC, supercomplexes containing 
CI, CIII and CIV (right panel). CIV*, putative complex IV dimer. (a.d.u.), arbitrary 
densitometric units. Mean values correspond to percentages relative to untreated cells 
(SS). Error bars represent standard deviations (SD). See also Figure S3. 
Figure 5. Comparative analysis of the incorporation rates of RC subunits into 
large supercomplexes. (A) Mean incorporation rates of RC subunits into I+III2+IVn 
supercomplexes (SC). SC2 represents the mean incorporation rates of NDUFA9, 
NDUFS2, CORE2, COX4 and COX5A subunits into SC. (B) 60 µg of crude 
mitochondrial pellets from the doxycycline assays were analyzed by BN-PAGE in 
combination with in-gel activity (IGA) assays. The left panel shows a CI in-gel activity 
(IGA) assay, where * indicate unspecific bands with NADH dehydrogenase activity. 
The right panel shows a CIV IGA assay. ** indicate the putative CIV dimer (CIV*) and 
supercomplex III2+IV that stained for CIV activity (CIVa). SCa indicates CI and CIV 
activities in large supercomplexes. (C) Densitometric analysis of the CI and CIV SCa 
bands performed in three independent experiments. (D) Spectrophotometric CI 
activities in digitonin-treated 143B cells. Triplicate measurements were normalized by 
the citrate synthase activity. (a.d.u.), arbitrary densitometric units. Mean values 
represent percentages relative to untreated cells (SS). Error bars represent standard 
deviations (SD). 
Figure 6. Analysis of mitochondrial supercomplexes in COX2 mutant cybrids (A) 
BN-PAGE was performed in COX2 mutant cybrids carrying a homoplasmic 
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m.7896G>A mutation (M) and an isogenic control (C), followed by CI and CIV IGA 
assays, or alternatively, blotted on nitrocellulose and incubated with the indicated 
antibodies. (B) 2D-BN/SDS-PAGE western-blot analysis in control (C) and the COX2 
mutant (M) cybrids using antibodies against the indicated OXPHOS subunits. 
Abbreviations as in Figure 1. See also Figure S4. 
Figure 7. Model for the assembly of mitochondrial supercomplexes. In a first stage, 
the syntheses of fully-assembled and active CIII and CIV take place until reaching a 
threshold that probably triggers the accumulation of free subunits and assembly 
intermediates from these two complexes. At this early stage the assembly of CI also 
initiates (steps 1 to 6) to building up a CI subassembly of  ̴830 kDa that constitutes the 
first supercomplex assembly intermediate (SC1). This subcomplex remains in a stable 
assembly-competent state for the subsequent binding of CIII subunit CORE2 and CIV 
subunits COX4 and COX5A, to form a second supercomplex assembly intermediate 
(SC2). The incorporations of CI NDUFS4 and CIV COX2 subunits, and maybe other 
free RC subunits or subassemblies, take place in a third stage (SC3). The catalytic CIII 
RISP and CIV COX1 subunits and the structural CIV subunit COX6C incorporate to the 
supercomplexes in a fourth stage (SC4). The latest supercomplex assembly step 
involves the association of catalytic subunits from the CI NADH dehydrogenase module 
prior to the respirasome activation (SC5).  
